Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Covidien Sells One Peripheral Device While Touting Data On Another

This article was originally published in The Gray Sheet

Executive Summary

Covidien announced it is selling its Stellarex drug-coated angioplasty balloon platform to Spectranetics for $30 million ahead of its merger with Medtronic, which makes the IN.PACT Admiral drug-coated balloon. But the company still plans to bring a significant peripheral vascular device portfolio along with it when it joins Medtronic.


Related Content

US Approvals Analysis: Drug-Coated Balloon, Valve Tech Are July Highlights


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts